GLRA1 (Glycine Receptor Alpha 1) encodes the alpha-1 subunit of the glycine receptor, a ligand-gated chloride channel that mediates inhibitory neurotransmission in the central nervous system. This gene is crucial for motor control, sensory processing, and reflex modulation.
GLRA1 is located on chromosome 5q33.1 and encodes a protein with four transmembrane domains. The glycine receptor is a pentameric ligand-gated ion channel (pLGIC) primarily composed of alpha and beta subunits. The alpha-1 subunit (GLRA1) is the predominant adult isoform and mediates fast inhibitory neurotransmission in the spinal cord and brainstem.
Key Points:
The GLRA1 protein contains:
The receptor assembles as a pentamer, typically as alpha1beta heteromers or alpha1 homomers. Each subunit contributes to forming the central chloride-conducting pore.
The GLRA1 gene encodes the Glycine Receptor Alpha-1, which mediates fast inhibitory neurotransmission in the spinal cord and brainstem. Glycine receptors play crucial roles in:
Glycine binding to GLRA1 opens the channel pore, allowing chloride ions to flow into the neuron, hyperpolarizing the membrane and inhibiting action potential generation.
Mutations in GLRA1 cause hyperekplexia, a neurological disorder characterized by:
In neurodegenerative diseases, GLRA1 may play a role through:
Glycine receptors containing the GLRA1 subunit are primarily expressed in:
During development, alpha-2 and alpha-3 subunits predominate, while alpha-1 becomes the main isoform in adulthood.
GLRA1 is a target for several therapeutic approaches:
Current research focuses on:
The study of Glra1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Betz H, et al. (1999). Structure and functions of inhibitory glycine receptors. Q Rev Biophys 32(2):131-164. DOI:10.1017/S0033583500003538
Lynch JW. (2004). Molecular structure and function of the glycine receptor chloride channel. Physiol Rev 84(4):1051-1095. DOI:10.1152/physrev.00042.2003
Rajendra S, et al. (1997). The glycine receptor. Pharmacol Ther 73(2):121-146. DOI:10.1016/S0163-7258(9600163-5
Laube B, et al. (2002). Modulation of glycine receptor function: a therapeutic approach? Neurochem Int 41(5):309-315. DOI:10.1016/S0197-0186(0200043-4
Bode A, Lynch JW. (2014). The impact of human hyperekplexia mutations on glycine receptor structure and function. Mol Brain 7:55. DOI:10.1186/s13041-014-0055-0
Chua HC, et al. (2016). Glycine receptors and excitatory neurotransmission in normal and pathological brain function. Neuropharmacology 105:555-566. DOI:10.1016/j.neuropharm.2016.05.015
Hirzel K, et al. (2006). Hyperekplexia phenotype of glycine receptor alpha1-subunit mutant mice identifies a novel receptor. Neuropsychopharmacology 31(10):2252-2261. DOI:10.1038/sj.npp.1300992
Winkelmann A, et al. (2018). Glycine receptors in the pathogenesis of neurodegenerative diseases. Mol Neurobiol 55(7):5353-5364. DOI:10.1007/s12035-017-0781-2